Pursuant to earlier intimation dated May 16 2023 regarding Board meeting on Wednesday, May 24,2023; Lotus Eye Hospital and Institute has informed that the Company shall consider the following in addition to Audited Standalone Financial Results of the company for the quarter and year ended March 31, 2023: Consideration and proposed recommendation of Final dividend. As per earlier intimation the trading window shall re-open from May 30 2023.
The above information is a part of company’s filings submitted to BSE.
